FHL3
four and a half LIM domains 3
FHL3; four and a half LIM domains 3; four and a half LIM domains protein 3; SLIM2; FHL 3; Skeletal muscle LIM protein 2; FHL-3; SLIM-2; LIM-only protein FHL3; skeletal muscle LIM-protein 2;
GIF
gastric intrinsic factor (vitamin B synthesis)
Gastric Intrinsic Factor; Gastric intrinsic factor (vitamin B synthesis); GIF; IF; IFMH; INF; Intrinsic factor; TCM3; TCN3; Intrinsic Factor Ab;
GINS2
GINS complex subunit 2 (Psf2 homolog)
GINS2; GINS complex subunit 2 (Psf2 homolog); DNA replication complex GINS protein PSF2; Pfs2; PSF2; anti PSF2; GINS complex subunit 2; HSPC037; OTTHUMP00000175001;
Ide
insulin-degrading enzyme
IDE; insulin-degrading enzyme; INSULYSIN; insulinase; insulin protease; Abeta-degrading protease;
IGF1
Insulin-like growth factor 1
ProIGF-I; Insulin-like Growth Factor-I Precursor; IGF-IEB; IGF1; IGFI; Insulin-like Growth Factor-I; insulin-like growth factor 1 (somatomedin C); insulin-like growth factor 1; IGF1A; insulin-like growth factor I; Mechano growth factor; insulin-like growth factor IA; IGF-I; insulin-like growth factor IB; MGF; somatomedin-C; IGF-IA; IBP1; IGF-IB; Somatomedin-C; IGFI; Teprotumumab; 89957-37-9; Ganitumab; 905703-97-1;
IGF1R
insulin-like growth factor 1 receptor
IGF1R; insulin-like growth factor 1 receptor; IGFR; CD221; IGFIR; JTK13; IGF-I receptor; soluble IGF1R variant 1; soluble IGF1R variant 2; insulin-like growth factor I receptor;
IGF2
Insulin-like Growth Factor-II
IGF2; IGF-II; PP9974; C11orf43; insulin-like growth factor 2 (somatomedin A); insulin-like growth factor II; insulin-like growth factor type 2; GF2; FLJ22066; FLJ44734; insulin-like growth factor 2 (somatomedin A); C11orf43, chromosome 11 open reading frame 43; insulin-like growth factor II; somatomedin-A; insulin-like growth factor type 2; PP9974;
IGF2R
Insulin-like Growth Factor 2 Receptor
cation-independent mannose-6-phosphate receptor; M6PR; CI-MPR; MPR 300; M6P/IGF2R; IGF-II receptor; M6P/IGF2 receptor; OTTHUMP00000017536; CI Man-6-P receptor; 300 kDa mannose 6-phosphate receptor; MPR1; insulin-like growth factor II receptor; cation-independent mannose-6 phosphate receptor; CD222 antigen; MPRI; CD222; CIMPR; M6P-R; IGF2R; insulin-like growth factor 2 receptor;
IGFBP1
Insulin-like Growth Factor Binding Protein 1
AFBP; IBP1; PP12; IGF-BP25; hIGFBP-1; IGFBP1; insulin-like growth factor-binding protein 1; IBP-1; IGFBP-1; OTTHUMP00000159561; OTTHUMP00000207990; OTTHUMP00000214348; binding protein-25; binding protein-26; binding protein-28; placental protein 12; IGF-binding protein 1; amniotic fluid binding protein; growth hormone independent-binding protein; alpha-pregnancy-associated endometrial globulin;
IGFBP2
insulin-like growth factor binding protein 2, 36kDa
IGFBP2; insulin-like growth factor binding protein 2, 36kDa; IBP2; IGF-BP53; insulin-like growth factor-binding protein 2; IBP-2; IGFBP-2; IGF-binding protein 2;
IGFBP3
IGFBP3 insulin-like growth factor binding protein 3
IGFBP3; insulin-like growth factor binding protein 3; insulin-like growth factor-binding protein 3; acid stable subunit of the 140 K IGF complex; binding protein 29; binding protein 53; BP 53; growth hormone dependent binding protein; IBP3; IGF binding protein 3; IBP-3; IGFBP-3; IGF-binding protein 3; growth hormone-dependent binding protein; BP-53;
IGFBP4
insulin-like growth factor binding protein 4
IGFBP4; insulin-like growth factor binding protein 4; BP-4; IBP4; IGFBP-4; HT29-IGFBP; insulin-like growth factor-binding protein 4; IBP-4; IGF-binding protein 4; Insulin-like growth factor-binding protein 4;
IGFBP5
insulin-like growth factor binding protein 5
IGFBP5; insulin-like growth factor binding protein 5; IBP5; insulin-like growth factor-binding protein 5; IBP-5; IGFBP-5; IGF-binding protein 5; Insulin-like growth factor-binding protein 5;
IGFBP6
IGFBP6 insulin-like growth factor binding protein 6
IGFBP6; insulin-like growth factor binding protein 6; insulin-like growth factor-binding protein 6; IBP-6; IGFBP-6; IGF binding protein 6; IGF-binding protein 6; IBP6;
IGFBP7
insulin-like growth factor binding protein 7
IGFBP7; insulin-like growth factor binding protein 7; AGM; PSF; TAF; FSTL2; IBP-7; MAC25; IGFBP-7; RAMSVPS; IGFBP-7v; IGFBPRP1; insulin-like growth factor-binding protein 7; IGFBP-rP1; angiomodulin; IGF-binding protein 7; PGI2-stimulating factor; tumor-derived adhesion factor; prostacyclin-stimulating factor;
INS
insulin
INS; insulin; ILPR; IRDN; IDDM1; IDDM2; MODY10; proinsulin; preproinsulin; insulin-dependent diabetes mellitus 2; OTTHUMP00000011161; OTTHUMP00000011162; OTTHUMP00000196036; OTTHUMP00000196038; OTTHUMP00000217519;
INSR
Insulin Receptor
CD220; CD220 antigen; HHF 5; INSR; INSR_HUMAN; Insulin receptor subunit beta; IR; Insulin Receptor;
INSRR
insulin receptor-related receptor
INSRR; insulin receptor-related receptor; insulin receptor-related protein; IRR; IR-related receptor;
Kdr
kinase insert domain receptor (a type III receptor tyrosine kinase)
KDR; kinase insert domain receptor (a type III receptor tyrosine kinase); FLK1; CD309; VEGFR; VEGFR2; vascular endothelial growth factor receptor 2; soluble VEGFR2; fetal liver kinase 1; fetal liver kinase-1; protein-tyrosine kinase receptor Flk-1; tyrosine kinase growth factor receptor;
KIR2DL1
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1
KIR2DL1; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1; killer cell immunoglobulin-like receptor 2DL1; 47.11; CD158A; cl 42; nkat1; p58.1; NKAT-1; killer Ig receptor; p58 NK receptor CL-42/47.11; MHC class I NK cell receptor; killer inhibitory receptor 2-2-1; CD158 antigen-like family member A; natural killer-associated transcript 1; p58 NK cell inhibitory receptor NKR-K6; p58.1 MHC class-I-specific NK receptor; p58 killer cell inhibitory receptor KIR-K64; p58 natural killer cell receptor clones CL-42/47.11; NKAT; KIR221; KIR-K64;
KIR2DL3
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3
KIR2DL3; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3; killer cell immunoglobulin-like receptor 2DL3; CD158B2; cl 6; nkat2; nkat2a; nkat2b; p58; CD158b; GL183; Killer Cell Immunoglobulin Like Receptor 2DL3; Killer inhibitory receptor CL2 3; KIR023GB; MHC Class I NK Cell Receptor; Natural Killer Associated Transcript 2; p58 Natural Killer Cell Receptor Clone CL6; p58 NK Receptor; p58.2 MHC Class I Specific NK Receptor; NKAT-2; NK-receptor; OTTHUMP00000068619; p58 NK receptor CL-6; killer inhibitory receptor cl 2-3; CD158 antigen-like family member B2; natural kill; NKAT; KIR-K7b; KIR-K7c; KIRCL23; KIR-023GB;
KIR2DL4
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4
KIR2DL4; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4; killer cell immunoglobulin-like receptor 2DL4; 15.212; 103AS; CD158D; KIR-103AS; NK cell receptor; killer Ig receptor; CD158 antigen-like family member D; MHC class;
KIR2DS4
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4
KIR2DS4; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4; killer cell immunoglobulin-like receptor 2DS4; CD158i; cl 39; KKA3; nkat8; CD158 antigen like family member I; CD158i antigen; CL 17; CL17; CL39; Killer cell immunoglobulin like receptortwo domains short cytoplasmic tail 4; Killer inhibitory receptor 4 1 2; KIR antigen 2DS4; KIR1D; KIR412; MGC120019; MGC125315; MGC125317; MHC class I NK cell receptor; Natural killer associated transcript 8; Natural killer cell inhibitory receptor; NKAT 8; P58 natural killer cell receptor clone CL 39; p58 NK receptor; NKAT-8; OTTHUMP00000199030; p58 NK receptor CL-39/CL-17; killer inhibitory receptor 4-1-2; CD158 antigen-like family member I; natural killer-associated transcript 8; na;
KIR3DL1
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
KIR3DL1; killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1; KIR; killer cell immunoglobulin-like receptor 3DL1; AMB11; CD158e1; CD158e1/2; CD158e2; cl 2; cl 11; nkat3; NKB1; NKB1B; CD158 antigen-like family member E; CD158E; CD158e antigen; CL11; CL2; HLA-BW4-specific inhibitory NK cell receptor; killer cell immunoglobulin like receptor; Killer cell immunoglobulin like receptor three domains , short cytoplasmic tail, 1; Killer cell immunoglobulin like receptor three domains long cytoplasmic tail 1; KIR antigen 3DL1; KIR G1; KIR3DS1; Kirl1; Kirl2; Krl1; MGC119726; MGC119728; MGC126589; MGC126591; MHC class I NK cell receptor; Natural killer associated transcript 3; Natural killer cell inhibitory receptor; NK receptor; NK-associated transcript 10; NK-associated transcript 3; NK-associated transcript 3delIg1; NKAT10; p70 killer cell inhibitory receptor; p70 natural killer cell receptor clones CL 2/CL 11; NKAT-3; NK-receptor; OTTHUMP00000068687; OTTHUMP00000068688; OTTHUMP00000081758; killer Ig receptor; p70 NK receptor CL-2/CL-11; p70 ki; KIR3DL1/S1;
LILRB3
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3
LILRB3; leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3; leukocyte immunoglobulin-like receptor subfamily B member 3; CD85a; HL9; ILT5; LIR 3; LIR3; CD85 antigen like family member A; CD85a antigen; IL T5; Immunoglobulin like transcript 5; Leukocyte immunoglobulin like receptor 3; Leukocyte immunoglobulin like receptor subfamily B (with TM and ITIM domains) member 3; Leukocyte immunoglobulin like receptor subfamily B member 3; MGC138403; Monocyte inhibitory receptor HL9; PIRB; ILT-5; OTTHUMP00000069587; OTTHUMP00000197712; OTTHUMP00000237014; immunoglobulin-like transcript 5; CD85 antigen-like family member A; leukocyte immunoglobulin-like re; LIR-3;
LMCD1
LIM and cysteine-rich domains 1
LMCD1; LIM and cysteine-rich domains 1; LIM and cysteine-rich domains protein 1; dyxin;
LOC100136741
insulin-like growth factor I
LOC100136741; insulin-like growth factor I; igf1; IGF-I; somatomedin;
MMP14
matrix metallopeptidase 14 (membrane-inserted)
MMP14; matrix metallopeptidase 14 (membrane-inserted); MMP-14; MMP-X1; MT-MMP; MT1MMP; MTMMP1; WNCHRS; MT1-MMP; MT-MMP 1; matrix metalloproteinase-14; membrane type 1 metalloprotease; membrane-type-1 matrix metalloproteinase; 1;
MMP15
matrix metallopeptidase 15 (membrane-inserted)
MMP15; matrix metallopeptidase 15 (membrane-inserted); MTMMP2; SMCP-2; MT2-MMP; matrix metalloproteinase-15; MMP-15; MT2MMP; MT-MMP 2; membrane-type matrix metalloproteinase 2; membrane-type-2 matrix metalloproteinase; matrix metalloproteinase 15 (membrane-inserted);
MMP16
matrix metallopeptidase 16 (membrane-inserted)
MMP16; matrix metallopeptidase 16 (membrane-inserted); MMP-X2; C8orf57; MT-MMP2; MT-MMP3; MT3-MMP; matrix metalloproteinase-16; MMP-16; MT3MMP; MTMMP3; MT-MMP 3; Putative transmembrane protein C8orf57; membrane-type matrix metalloproteinase 3; membrane-type-3 matrix metalloproteinase;
MMP17
matrix metallopeptidase 17 (membrane-inserted)
MMP17; matrix metallopeptidase 17 (membrane-inserted); MT4-MMP; matrix metalloproteinase-17; MMP-17; MT4MMP; MTMMP4; MT-MMP 4; membrane-type matrix metalloproteinase 4; membrane-type-4 matrix metalloproteinase; matrix metalloproteinase 17 (membrane-inserted);
MMP24
matrix metallopeptidase 24 (membrane-inserted)
MMP24; matrix metallopeptidase 24 (membrane-inserted); MMP25; MMP-24; MT5MMP; MTMMP5; MT-MMP5; MT5-MMP; MT-MMP 5; matrix metalloproteinase-24; membrane-type 5 matrix metalloproteinase; membrane-type matrix metalloproteinase 5; membrane-type-5 matrix metalloproteinase; matrix metalloproteinase 24 (membrane-inserted);
MS4A1
membrane-spanning 4-domains, subfamily A, member 1
MS4A1; membrane-spanning 4-domains, subfamily A, member 1; B1; S7; Bp35; CD20; CVID5; MS4A2; LEU-16; B-lymphocyte antigen CD20; CD20 antigen; CD20 receptor; leukocyte surface antigen Leu-16; B-lymphocyte cell-surface antigen B1;
PARK7
parkinson protein 7
PARK7; parkinson protein 7; DJ1; DJ-1; HEL-S-67p; protein DJ-1; oncogene DJ1; epididymis secretory sperm binding protein Li 67p; Parkinson disease (autosomal recessive, early onset) 7;
TES
testis derived transcript (3 LIM domains)
TES; testis derived transcript (3 LIM domains); testin; DKFZP586B2022; TESS 2; TESS; TESS-2; MGC1146;
TIE1
TIE1 tyrosine kinase with immunoglobulin-like and EGF-like domains 1
TIE1; tyrosine kinase with immunoglobulin-like and EGF-like domains 1; TIE, tyrosine kinase with immunoglobulin and epidermal growth factor homology domains 1; tyrosine-protein kinase receptor Tie-1; JTK14; tyrosine kinase with immunoglobulin and epidermal growth factor homology domains 1; TIE;
TIGIT
T cell immunoreceptor with Ig and ITIM domains
TIGIT; T cell immunoreceptor with Ig and ITIM domains; V set and immunoglobulin domain containing 9 , V set and transmembrane domain containing 3 , VSIG9, VSTM3; T-cell immunoreceptor with Ig and ITIM domains; DKFZp667A205; FLJ39873; V-set and transmembrane domain containing 3; V-set and immunoglobulin domain containing 9; Washington University cell adhesion molecule; V-set and transmembrane domain-containing protein 3; V-set and immunoglobulin domain-containing protein 9; VSIG9; VSTM3; WUCAM;
FHL2
four and a half LIM domains 2
FHL2; four and a half LIM domains 2; four and a half LIM domains protein 2; DRAL; SLIM3; LIM domain protein DRAL; aging-associated gene 11; skeletal muscle LIM-protein 3; four and a half LIM-domain protein 2; down-regulated in rhabdomyosarcoma LIM protein;
IGFPB2
Insulin-Like Growth Factor Binding Protein 2, 36kDa
BP2; IBP2; IBP-2; IGF-binding protein 2; IGFBP2; IGFBP-2; IGF-BP53; insulin-like growth factor binding protein 2 (36kD); insulin-like growth factor binding protein 2, 36kDa; insulin-like growth factor-binding protein 2; OTTHUMP00000207751; OTTHUMP00000207753.;
IGFPB6
Insulin-Like Growth Factor Binding Protein 6
IGFBP6; insulin-like growth factor binding protein 6; IBP6; IGF binding protein 6; Insulin-like growth factor-binding protein 6; IGF-binding protein 6; IGFBP-6; IBP-6;
LRIT3
leucine-rich repeat, immunoglobulin-like and transmembrane domains 3
LRIT3; leucine-rich repeat, immunoglobulin-like and transmembrane domains 3; leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 3; fibronectin type III; immunoglobulin and leucine rich repeat domains 4; FIGLER4; FLJ44691; immunoglobulin-like domain and transmembrane domain-containing protein 3; Leucine-rich repeat; leucine-rich repeat, immunoglobulin like and transmembrane domains 3; LRIT3 protein; LRIT3_HUMAN; MGC120618; OTTHUMP00000205710; fibronectin type III, immunoglobulin and leucine rich repeat domains 4;
AAAS
achalasia, adrenocortical insufficiency, alacrimia
AAAS; achalasia, adrenocortical insufficiency, alacrimia; achalasia, adrenocortical insufficiency, alacrimia (Allgrove, triple A); aladin; Allgrove; triple A; Allgrove, triple-A; AAA; AAASb; GL003; ADRACALA; ADRACALIN; DKFZp586G1624;
ACAP2
ArfGAP with coiled-coil, ankyrin repeat and PH domains 2
ACAP2; ArfGAP with coiled-coil, ankyrin repeat and PH domains 2; centaurin, beta 2 , CENTB2; arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2; CNT B2; KIAA0041; ACAP 2; Arf GAP with coiled coil ANK repeat and PH domains 2; CENT B 2; Centaurin beta2; CENTB 2; CENTB2; Cntb2; Similar to yeast ZINC FINGER PROTEIN GCS1; centaurin-beta-2; centaurin, beta 2; OTTHUMP00000208844; Arf GAP with coiled coil, ANK repeat and PH domains 2; CNT-B2;
CHFR
checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase
CHFR; checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase; RNF116; RNF196; E3 ubiquitin-protein ligase CHFR; RING finger protein 196;
DAD1
Defender Against Cell Death 1
OST2; DAD1; Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1; Oligosaccharyl transferase subunit DAD1; EC=2.4.1.119; Defender against cell death 1; AD-1; OTTHUMP00000164488; OTTHUMP00000239715; OTTHUMP00000239717; DAD-1; dolichyl-diphosphooligosaccharide--protein glycosyltransfe-rase subunit DAD1; EC 2.4.1.119; oligosaccharyltransferase 2 homolog;
FHL5
four and a half LIM domains 5
FHL5; four and a half LIM domains 5; four and a half LIM domains protein 5; ACT; dJ393D12.2; FLJ33049; Activator of cAMP responsive element modulator (CREM) in testis; Activator of CREM in testis; FHL5 protein; FHL-5; 1700027G07Rik; LIM protein ACT; OTTHUMP00000016879; OTTHUMP00000016880; activator of cAMP-responsive element modulator in testis; activator of cAMP-responsive element modulator (CREM) in t; RP3-393D12.2;
IRS4
Insulin receptor substrate 4
IRS4; nsulin receptor substrate 4; pp160; phosphoprotein of 160 kDa; 160 kDa phosphotyrosine protein; IRS-4; PY160;
KANK1
KN motif and ankyrin repeat domains 1
KANK1; KN motif and ankyrin repeat domains 1; ANKRD15, ankyrin repeat domain 15; KN motif and ankyrin repeat domain-containing protein 1; KANK; KIAA0172; ANKRD 15; Ankyrin repeat domain 15; Ankyrin repeat domain containing protein 15; DKFZp451G231; Kidney ankyrin repeat containing protein; MGC43128; OTTHUMP00000020957; OTTHUMP00000082438; OTTHUMP00000082439; kidney ankyrin repeat-containing protein; ankyrin repeat domain-containing protein 15; CPSQ2; ANKRD15;
LILRB1
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
LILRB1; leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1; leukocyte immunoglobulin-like receptor subfamily B member 1; CD85; CD85j; ILT2; LIR 1; LIR1; MIR 7; ILT-2; CD85 antigen; Ig-like transcript 2; leukocyte Ig-like receptor-1; immunoglobulin-like transcript 2; CD85 antigen-like family member J; leukocyte immunoglobulin-like receptor 1; monocyte/macrophage immunoglobulin-like receptor 7; leukocyte immunoglobulin-like receptor subfamily B member 1 soluble isoform; MIR7; LIR-1; MIR-7; FLJ37515;
LILRB2
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2
LILRB2; leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2; leukocyte immunoglobulin-like receptor subfamily B member 2; CD85d; ILT4; LIR 2; LIR2; MIR 10; MIR10; ILT-4; Ig-like transcript 4; immunoglobulin-like transcript 4; CD85 antigen-like family member D; leukocyte immunoglobulin-like receptor 2; monocyte/macrophage immunoglobulin-like receptor 10; leukocyte immunoglobulin-like receptor subfamily B member 2 soluble isoform; eukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6; LIR-2; LILRA6; MIR-10;
LIMS1
LIM and senescent cell antigen-like domains 1
LIMS1; LIM and senescent cell antigen-like domains 1; PINCH; PINCH1; PINCH-1; LIM and senescent cell antigen-like-containing domain protein 1; renal carcinoma antigen NY-REN-48; particularly interesting new Cys-His protein 1;
MS4A12
membrane-spanning 4-domains, subfamily A, member 12
MS4A12; membrane-spanning 4-domains, subfamily A, member 12; membrane-spanning 4-domains subfamily A member 12; FLJ20217; Ms4a10; Membrane spanning 4 domains subfamily A member 12; OTTHUMP00000229465; OTTHUMP00000229466;
MS4A7
membrane-spanning 4-domains, subfamily A, member 7
MS4A7; membrane-spanning 4-domains, subfamily A, member 7; membrane-spanning 4-domains subfamily A member 7; CD20L4; CFFM4; MS4A8; 4SPAN2; CD20 antigen like 4; CD20/Fc epsilon RI beta family member 4; Four span transmembrane protein 2; High affinity immunoglobulin epsilon receptor beta subunit; Membrane spanning 4 domains subfamily A member 7; MGC22368; OTTHUMP00000235790; OTTHUMP00000235791; OTTHUMP00000235792; OTTHUMP00000236358; CD20 antigen-like 4; four-span transmembrane protein 2; CD20/Fc-epsilon-RI-beta family member 4; high affinity immunoglobulin epsilon;
PARK2
parkinson protein 2, E3 ubiquitin protein ligase (parkin)
PARK2; PDJ; PRKN; AR-JP; LPRS2; parkin; parkinson protein 2, E3 ubiquitin protein ligase (parkin); E3 ubiquitin-protein ligase parkin; parkin 2; OTTHUMP00000017562; OTTHUMP00000017563; OTTHUMP00000017564; OTTHUMP00000017565; OTTHUMP00000017566; OTTHUMP00000017567; E3 ubiquitin ligase; parkinson disease protein 2; parkinson juvenile disease protein 2; Parkinson disease (autosomal recessive, juvenile) 2, parkin; EC 6.3.2.-;
RXFP1
relaxin/insulin-like family peptide receptor 1
RXFP1; relaxin/insulin-like family peptide receptor 1; leucine rich repeat containing G protein coupled receptor 7 , LGR7; relaxin receptor 1; RXFPR1; leucine-rich repeat-containing G protein-coupled receptor 7; LGR7; MGC138347; MGC142177;
SFMBT1
Scm-like with four mbt domains 1
SFMBT1; Scm-like with four mbt domains 1; scm-like with four MBT domains protein 1; DKFZp434L243; RU1; SFMBT; renal ubiquitous protein 1; Scm-related gene containing four mbt domains; Scm-related gene product containing four mbt domains;
SRCRB4D
scavenger receptor cysteine rich domain containing, group B (4 domains)
SRCRB4D; scavenger receptor cysteine rich domain containing, group B (4 domains); scavenger receptor cysteine-rich domain-containing group B protein; S4D SRCRB; scavenger receptor cysteine rich protein SRCRB S4D; SRCRB S4D; SSC4D; Scavenger receptor cysteine rich domain containing group B (4 domains); Scavenger receptor cysteine rich domain containing group B; S4-SRCRB; OTTHUMP00000161135; scavenger receptor cysteine-rich protein SRCRB-S4D; S4D-SRCRB; SRCRB-S4D;
TCOF1
Treacher Collins-Franceschetti syndrome 1
TCOF1; Treacher Collins-Franceschetti syndrome 1; treacle protein; treacle; MFD1; TCOF 1; TCOF_HUMAN; Treacher Collins syndrome protein; OTTHUMP00000160560; OTTHUMP00000224041; OTTHUMP00000224042; OTTHUMP00000224043; OTTHUMP00000224077; OTTHUMP00000227678; OTTHUMP00000231643; nucleolar trafficking phosphoprotein; TCS1;
TMEFF2
transmembrane protein with EGF-like and two follistatin-like domains 2
TMEFF2; transmembrane protein with EGF-like and two follistatin-like domains 2;
UBRF2
Ubiquitin-like With PHD And Ring Finger Domains 2
UHRF2; DKFZp434B0920; DKFZp686G0837; E3 ubiquitin-protein ligase UHRF2; EC 6.3.2.; MGC33463; NIRF; Np95/ICBP90-like RING finger protein; np95/ICBP90-like RING finger protein; Np95-like ring finger protein; Nuclear protein 97; nuclear protein 97; Nuclear zinc finger protein Np97; nuclear zinc finger protein NP97; OTTHUMP00000021047; RING finger protein 107; RNF107; RP11-472F14.2; Ubiquitin-like PHD and RING finger domain-containing protein 2; ubiquitin-like PHD and RING finger domain-containing protein 2; ubiquitin-like with PHD and ring finger domains 2; ubiquitin-like, containing PHD and RING finger domains, 2; ubiquitin-like-containing PHD and RING finger domains protein 2; Ubiquitin-like-containing PHD and RING finger domains protein 2; URF2;
UHRF1
ubiquitin-like, containing PHD and RING finger domains, 1
UHRF1; ubiquitin-like, containing PHD and RING finger domains, 1; E3 ubiquitin-protein ligase UHRF1; nuclear protein 95; nuclear zinc finger protein Np95; ubiquitin-like PHD and RING finger domain-containing protein 1; ubiquitin-like-containing PHD and RI;
IGF2BP2
Insulin-like growth factor 2 mRNA binding protein 2
RP23-50H13.1; C330012H03Rik; IMP-2; Imp2; Neilsen; IGF-II mRNA-binding protein 2; IGF2 mRNA-binding protein 2; VICKZ family member 2; insulin-like growth factor 2 mRNA-binding protein 2; insulin-like growth factor 2, binding protein 2;
CDC2L2
cell division cycle 2-like 2 (PITSLRE proteins)
CDC2L2;cell division cycle 2-like 2 (PITSLRE proteins);CDC2L2, CDC2L3, cell division cycle 2 like 2, cell division cycle 2 like 2 (PITSLRE proteins);cell division cycle 2-like 2;CDK11 p46;CDK11 p58;CDK11 p110;p58GTA;PITSLRE;CDC2L3;CDK11-p46;CDK11-p58;CDK11-p110;MGC131975;Q9UQ88;cyclin-dependent kinase 11A;EC 2.7.11.22;OTTHUMP00000000760;OTTHUMP00000000762;OTTHUMP00000000763;OTTHUMP00000000764;OTTHUMP00000000767;Cell division cycle 2-like protein kinase 2;OTTHUMP00000000768;Cell division protein kinase 11A;PITSLRE B;Galactosyltransferase-associated protein kinase p58/GTA;PITSLRE protein kinase beta;PITSLREB;PITSLRE serine/threonine-protein kinase CDC2L2;EC 2.7.11;
CRELD2
cysteine-rich with EGF-like domains 2
CRELD2; cysteine-rich with EGF-like domains 2; cysteine-rich with EGF-like domain protein 2; MGC11256; CREL2_HUMAN; CRELD 2; Cysteine rich with EGF like domain protein 2; Cysteine rich with EGF like domains 2; DKFZp667O055;
DOC2A
double C2-like domains, alpha
DOC2A;double C2-like domains, alpha;double C2-like domain-containing protein alpha;doc2-alpha;Doc2;
EDIL3
EGF-like repeats and discoidin I-like domains 3
EDIL3; EGF-like repeats and discoidin I-like domains 3; DEL1; EGF-like repeat and discoidin I-like domain-containing protein 3; integrin-binding protein DEL1; developmental endothelial locus-1; developmentally-regulated endothelial cell locus 1 protein;
EGFLAM
EGF-like, fibronectin type III and laminin G domains
EGFLAM; EGF-like, fibronectin type III and laminin G domains; pikachurin; AGRINL; AGRNL; FLJ39155; EGF-like, fibronectin type-III and laminin G-like domain-containing protein; agrin-like protein;
FASTKD2
FAST kinase domains 2
FASTKD2; FAST kinase domains 2; KIAA0971; FAST kinase domain-containing protein 2; FAST kinase domain containing protein 2;
FCHSD1
FCH and double SH3 domains 1
FCHSD1; FCH and double SH3 domains 1; FCH and double SH3 domains protein 1; FLJ00007; FCHSD 1; FCSD1_HUMAN; Nervous wreck homolog 2; NWK 2; NWK2;
IGF2BP3
insulin-like growth factor 2 mRNA binding protein 3
IGF2BP3; insulin-like growth factor 2 mRNA binding protein 3; insulin-like growth factor 2 mRNA-binding protein 3; cancer/testis antigen 98; CT98; IGF II mRNA binding protein 3; IMP 3; hKOC; VICKZ family member 3; IGF2 mRNA-binding protein 3; IGF-II mRNA-binding protein 3; KH domain containing protein overexpressed in cancer; KH domain-containing protein overexpressed in cancer; IMP3; KOC1; IMP-3; VICKZ3; DKFZp686F1078; OTTHUMP00000158561; VICKZ3.;
KIR2DL2
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2
KIR2DL2; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2; killer cell immunoglobulin-like receptor 2DL2; CD158B1; CD158k; cl 43; nkat6; CD158 antigen-like family member B1; CD158b; KI2L2_HUMAN; MHC class I NK cell receptor; Natural killer-associated transcript 6; NKAT 6; NKAT-6; p58 natural killer cell receptor clone CL-43; p58 NK receptor CL-43; p58.2;
MS4A2
membrane-spanning 4-domains, subfamily A, member 2
MS4A2; membrane-spanning 4-domains, subfamily A, member 2; APY, FCER1B, IgE responsiveness (atopic) , IGER, membrane spanning 4 domains, subfamily A, member 2 (Fc fragment of IgE, high affinity I, receptor for; beta polypeptide); high affinity immunoglo;
MS4A6A
membrane-spanning 4-domains, subfamily A, member 6A
MS4A6A; membrane-spanning 4-domains, subfamily A, member 6A; MS4A6; membrane-spanning 4-domains subfamily A member 6A; CD20L3; 4SPAN3; 4SPAN3.2; CD20 antigen like 3; CDA01; Four span transmembrane protein 3.1; Four span transmembrane protein 3.2; HAIRB iso; Membrane spanning 4 domains subfamily A member 6A; MS4A6A polymorph; MST090; MSTP090; HAIRB-iso; MS4A6A-polymorph; CD20-like precusor; CD20 antigen-like 3; four-span transmembrane protein 3; four-span transmembrane protein 3.1; four-span transmembrane protein 3.2; membrane-spanning 4-domains, subfamily A, member 6A, isoform 2;
MS4A8B
membrane-spanning 4-domains, subfamily A, member 8B
MS4A8B; membrane-spanning 4-domains, subfamily A, member 8B; membrane-spanning 4-domains subfamily A member 8B; MS4A4; Four span transmembrane protein 4; Membrane spanning 4 domains subfamily A member 8B; four-span transmembrane protein 4; 4SPAN4;
PAG1
phosphoprotein associated with glycosphingolipid microdomains 1
PAG1; phosphoprotein associated with glycosphingolipid microdomains 1; phosphoprotein associated with glycosphingolipid-enriched microdomains 1; CBP; Csk binding protein; PAG; transmembrane adaptor protein PAG; Csk-binding protein; transmembrane phosphoprotein Cbp; transmembrane adapter protein PAG; FLJ37858; MGC138364;
RXFP3
relaxin/insulin-like family peptide receptor 3
RXFP3; relaxin/insulin-like family peptide receptor 3; SALPR; RLN3R1; RXFPR3; GPCR135; relaxin-3 receptor 1; RLN3 receptor 1; relaxin 3 receptor 1; G-protein coupled receptor SALPR; g protein-coupled receptor SALPR; relaxin family peptide receptor 3; G-protein coupled receptor GPCR135; somatostatin and angiotensin-like peptide receptor; somatostatin- and angiotensin-like peptide receptor;
SPOCK3
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3
SPOCK3; sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3; testican-3; testican 3; HSAJ1454; OTTHUMP00000219853; OTTHUMP00000219854; OTTHUMP00000219857; OTTHUMP00000219858; OTTHUMP00000219862; OTTHUMP00000219864; OTTHUMP00000219865; OTTHUMP00000219866; OTTHUMP00000219867; OTTHUMP00000219868; Sparc/osteonectin, cwcv and kazal like domains proteoglycan (testican) 3; SPARC/osteonectin, CWCV, and Kazal like domains proteoglycan 3; TES 3; TICN3; TES-3;
UHRF2
ubiquitin-like with PHD and ring finger domains 2, E3 ubiquitin protein ligase
UHRF2; ubiquitin-like with PHD and ring finger domains 2, E3 ubiquitin protein ligase; ubiquitin like with PHD and ring finger domains 2; E3 ubiquitin-protein ligase UHRF2; MGC33463; NIRF; Np95 like ring finger protein; RNF107; URF2; nuclear protein 97; R;
ZKSCAN1
zinc finger with KRAB and SCAN domains 1
ZKSCAN1; zinc finger with KRAB and SCAN domains 1; zinc finger protein 36 (KOX 18) , ZNF36, ZNF139; zinc finger protein with KRAB and SCAN domains 1; KOX18; PHZ 37; MGC138429; MGC63357; Zinc finger protein 139; Zinc finger protein 36 (KOX 18); Zinc finger protein 36; Zinc finger protein KOX18; ZKSC1_HUMAN; ZNF139; ZNF36; PHZ-37; 9130423L19Rik;
ZKSCAN5
zinc finger with KRAB and SCAN domains 5
ZKSCAN5; zinc finger with KRAB and SCAN domains 5; ZFP95, zinc finger protein 95 homolog (mouse) , zinc finger protein homologous to Zfp95 in mouse; zinc finger protein with KRAB and SCAN domains 5; ZNF914; FLJ39233; HGNC:12867; KIAA1015; MGC33710; Zfp 95; ZFP95; Zinc finger protein 95 homolog; zfp-95; zinc finger protein homologous to Zfp95 in mouse;
KIR3DX1
killer cell immunoglobulin-like receptor, three domains, X1
killer cell immunoglobulin-like receptor, three domains, X1; FLJ00060; KIR3DL0; LENG12; leukocyte receptor cluster (LRC) member 12; Leukocyte receptor cluster member 12; KIR3DX1;
LRIG3
leucine-rich repeats and immunoglobulin-like domains 3
LRIG3; leucine-rich repeats and immunoglobulin-like domains 3; leucine-rich repeats and immunoglobulin-like domains protein 3; FLJ90440; KIAA3016; LIG3; LRIG1-3; LIG-3; OTTHUMP00000242498; OTTHUMP00000242499; OTTHUMP00000242500;
MS4A15
membrane-spanning 4-domains, subfamily A, member 15
MS4A15; membrane-spanning 4-domains, subfamily A, member 15; membrane-spanning 4-domains subfamily A member 15; FLJ34527; Hypothetical protein MGC35295; Membrane spanning 4 domains subfamily A member 15; MGC35295;
TMEFF1
transmembrane protein with EGF-like and two follistatin-like domains 1
TMEFF1; transmembrane protein with EGF-like and two follistatin-like domains 1; TR-1; H7365; C9orf2; CT120.1; tomoregulin-1; cancer/testis antigen family 120, member 1; transmembrane protein with EGF-like and one follistatin-like domain;
ZKSCAN3
zinc finger with KRAB and SCAN domains 3
ZKSCAN3; zinc finger with KRAB and SCAN domains 3; zinc finger protein 306 , zinc finger protein 309 , ZNF306, ZNF309; zinc finger protein with KRAB and SCAN domains 3; dJ874C20.1; ZF47; Zfp47; mszf35; SCAN-KRAB-zinc finger protein; Skz1; Zfp-47; ZFP306; Zfp307; Zinc finger and SCAN domain containing protein 13; Zinc finger and SCAN domain-containing protein 13; Zinc finger protein 306; Zinc finger protein 306, isoform CRA_a; Zinc finger protein 307; Zinc finger protein 309; Zinc finger protein 47 homolog; Zinc finger protein with KRAB and SCAN domains3; Zinc finger protein zfp47; ZKSC3_HUMAN; ZNF309; ZSCAN13; OTTHUMP00000016204; ZNF306; dJ874C20.1.;
ZKSCAN4
zinc finger with KRAB and SCAN domains 4
ZKSCAN4; zinc finger with KRAB and SCAN domains 4; zinc finger protein 307 , zinc finger protein 427 , ZNF307, ZNF427; zinc finger protein with KRAB and SCAN domains 4; FLJ32136; P1P373C6; p373c6.1; p373c6.1 (novel C2H2 type zinc finger protein); Zinc finger protein 307; Zinc finger protein 427; ZKSC4_HUMAN; ZNF307; ZNF427;
ADAP1
ArfGAP with dual PH domains 1
ADAP1; ArfGAP with dual PH domains 1; arf-GAP with dual PH domain-containing protein 1; CENTA1; Centaurin, alpha 1; GCS1L; p42IP4; Putative MAPK activating protein PM25; inositol(1,3,4,5)tetrakisphosphate receptor;
FHL1
four and a half LIM domains 1
FHL1; four and a half LIM domains 1; four and a half LIM domains protein 1; bA535K18.1; FHL1B; FLH1A; KYO T; LIM protein SLIMMER; MGC111107; SLIM1; XMPMA; FHL 1; FHL 1B; FHL-1; FHL1 protein; FHL1_HUMAN; FHL1A; Four and a half Lin11 Isl 1 and Mec 3 domains 1; RAM14-1; RBP associated molecule 14-1; Skeletal muscle LIM protein 1; Skeletal muscle LIM-protein 1; SLIM 1; SLIM; SLIM-1; SLIMMER; OTTHUMP00000024097; OTTHUMP00000024098; OTTHUMP00000024099; OTTHUMP00000024100; OTTHUMP00000024101; OTTHUMP00000024102; OTTHUMP00000024103; OTTHUMP00000024104; OTTHUMP00000024106; OTTHUMP00000024107; skeleta; KYOT;
LOC442228
similar to dJ22I17.2 (novel protein with EGF-like and laminin G domains)
LOC442228; similar to dJ22I17.2 (novel protein with EGF-like and laminin G domains); similar to dJ22I17.2 (novel protein with EGF-like and laminin G; dJ22I17.2;
SHANK1
SH3 and multiple ankyrin repeat domains 1
SHANK1; SH3 and multiple ankyrin repeat domains 1; SH3 and multiple ankyrin repeat domains protein 1; somatostatin receptor interacting protein; SPANK 1; SSTRIP; synamon; SSTR-interacting protein; somatostatin receptor-interacting protein; SPANK-1;
PHRF1
PHD and ring finger domains 1
PHRF1; PHD and ring finger domains 1; RNF221; PHD and RING finger domain-containing protein 1; CTD binding SR like protein rA9; KIAA1542; AA673488; PHD and RING finger domain containing protein 1; PHRF 1; OTTHUMP00000228596; OTTHUMP00000228597; OTTHUMP00000228598; OTTHUMP00000237921; OTTHUMP00000237922; CTD-binding SR-like protein rA9;
HRK
harakiri, BCL2 interacting protein (contains only BH3 domain)
HRK; DP5; HARAKIRI; harakiri, BCL2 interacting protein (contains only BH3 domain); activator of apoptosis hara-kiri; activator of apoptosis Hrk; Neuronal death protein DP5; BCL2-interacting protein; BH3-interacting domain-containing protein 3; death protein 5; harakiri, BCL2-interacting protein (contains only BH3 domain); BID3;
ABI5
protein abscisic acid-insensitive 5
ABI5; protein abscisic acid-insensitive 5; ABA Insensitive 5; AT2G36270; DNA binding / transcription activator/ transcription factor; F2H17.12; F2H17_12; GIA1; Growth insensitivity to ABA 1; Basic-leucine zipper (bZIP) transcription factor family protein ABA INSENSITIVE 5 (ABI5); CONTAINS InterPro DOMAIN/s: Basic-leucine zipper (bZIP) transcription factor (InterPro:IPR004827), bZIP transcription factor, bZIP-1 (InterPro:IPR011616); BEST Arabidopsis thaliana protein match is: abscisic acid responsive element-binding factor 1 (TAIR:AT1G49720.1); Has 3780 Blast hits to 3404 proteins in 335 species: Archae - 4; Bacteria - 363; Metazoa - 820; Fungi - 233; Plants - 1594; Viruses - 12; Other Eukaryotes - 754 (source: NCBI BLink).; GROWTH-INSENSITIVITY TO ABA 1;
MIP
major intrinsic protein of lens fiber
MIP; major intrinsic protein of lens fiber; lens fiber major intrinsic protein; MP26; MIP26; aquaporin-0; major intrinsic protein of eye lens fiber; Aqp0;
ACAP3
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3
ACAP3; ArfGAP with coiled-coil, ankyrin repeat and PH domains 3; centaurin, beta 5 , CENTB5; arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3; KIAA1716; Centaurin, beta 5; Centaurin-beta-5; CENTB5; Cnt-b5; OTTHUMP00000002288;
IGFALS
insulin-like growth factor binding protein, acid labile subunit
IGFALS; insulin-like growth factor binding protein, acid labile subunit; insulin-like growth factor-binding protein complex acid labile subunit; ALS; insulin-like growth factor binding protein complex acid labile chain;
KANK2
KN motif and ankyrin repeat domains 2
KANK2; KN motif and ankyrin repeat domains 2; ANKRD25, ankyrin repeat domain 25 , matrix remodelling associated 3 , MXRA3; KN motif and ankyrin repeat domain-containing protein 2; KIAA1518; SRC1-interacting protein; ankyrin repeat domain 25; SRC-1 inter;
RMI1
RMI1, RecQ mediated genome instability 1, homolog (S. cerevisiae)
RMI1; RMI1, RecQ mediated genome instability 1, homolog (S. cerevisiae); C9orf76, chromosome 9 open reading frame 76; recQ-mediated genome instability protein 1; BLAP75; BLM Associated Polypeptide; 75 kDa; FLJ12888; BLM-associated protein of 75 kDa; C9orf76; FAAP75; RMI1 homolog; RMI1_HUMAN; BLM-associated protein 75 kDa; BLM-Associated Polypeptide, 75 kDa; homolog of yeast RecQ-mediated genome instability 1 (RMI1); RP11-346I8.1;
BZW1
basic leucine zipper and W2 domains 1
BZW1; basic leucine zipper and W2 domains 1; basic leucine zipper and W2 domain-containing protein 1; BZAP45; KIAA0005; Basic leucine zipper and W2 domain containing protein 1; basic leucine-zipper protein BZAP45; BZW1_HUMAN; Nbla10236; Protein Orf; putative protein product of Nbla10236;
BZW2
basic leucine zipper and W2 domains 2
BZW2; basic leucine zipper and W2 domains 2; basic leucine zipper and W2 domain-containing protein 2; HSPC028; MST017; MSTP017; Basic leucine zipper and W2 domain containing protein 2; BZW 2;
ACAP1
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1
ACAP1; ArfGAP with coiled-coil, ankyrin repeat and PH domains 1; centaurin, beta 1 , CENTB1; arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 1; KIAA0050; ANK repeat and PH domain-containing protein 1; ACAP 1; ACAP1_HUMAN; Arf GAP with coiled coil ANK repeat and PH domains 1; Arf GAP with coiled coil, ankyrin repeat, and pleckstrin homology domains 1; Arf-GAP with coiled-coil; CENT B1; Centaurin beta 1; Centaurin-beta-1; CENTB 1; Cnt b1; Cnt-b1; Cntb1; centaurin, beta 1; OTTHUMP00000128386; Arf GAP with coiled coil, ANK repeat and PH domains 1; CENTB1;
CCBE1
collagen and calcium binding EGF domains 1
CCBE1; collagen and calcium binding EGF domains 1; collagen and calcium-binding EGF domain-containing protein 1; FLJ30681; KIAA1983; CCBE 1; CCBE1_HUMAN; Collagen and calcium binding EGF domain containing protein 1; Full of fluid protein homolog;
CENPBD1
CENPB DNA-binding domains containing 1
CENPBD1; CENPB DNA-binding domains containing 1; CENPB DNA-binding domain-containing protein 1; MGC16385; CENP1_HUMAN; FLJ23771; FLJ31569; MGC13198;
ADAP2
ArfGAP with dual PH domains 2
ADAP2; ArfGAP with dual PH domains 2; CENTA2; cent-b; HSA272195; arf-GAP with dual PH domain-containing protein 2; cnt-a2; centaurin beta; centaurin-alpha-2; centaurin, alpha 2; centaurin-alpha 2 protein;
CUBN
cubilin (intrinsic factor-cobalamin receptor)
CUBN; cubilin (intrinsic factor-cobalamin receptor); IFCR; MGA1; gp280; cubilin; 460 kDa receptor; cubilin precursor variant 1; cubilin precursor variant 2; intestinal intrinsic factor receptor; intrinsic factor-vitamin B12 receptor;
FASTKD3
FAST kinase domains 3
FASTKD3; FAST kinase domains 3; FAST kinase domain-containing protein 3; FLJ23274; MGC5297; FAST kinase domain containing protein 3; MGC142123;
FASTKD1
FAST kinase domains 1
FASTKD1; FAST kinase domains 1; FAST kinase domain-containing protein 1; FLJ21901; FAST kinase domain containing protein 1; KIAA1800; OTTHUMP00000207008; OTTHUMP00000207010;
FASTKD5
FAST kinase domains 5
FASTKD5; FAST kinase domains 5; FAST kinase domain-containing protein 5; FLJ13149; dJ1187M17.5; FAST kinase domain containing protein 5; FLJ58294;
DOC2B
double C2-like domains, beta
DOC2B; double C2-like domains, beta; DOC2BL, double C2 like domains, beta like; double C2-like domain-containing protein beta; Double C2 like domain containing protein beta; Doc2 beta; Doc2-beta; DOC2B_HUMAN; DOC2BL; Double C2 like domains beta; Double C2 like domains beta like; OTTMUSP00000006522; RP23 78H4.2; double C2-like domains, beta-like;
FANK1
fibronectin type III and ankyrin repeat domains 1
FANK1; fibronectin type III and ankyrin repeat domains 1; fibronectin type 3 and ankyrin repeat domains 1; fibronectin type 3 and ankyrin repeat domains protein 1; 1700007B22Rik; HSD13;
PLEKHD1
pleckstrin homology domain containing, family D (with coiled-coil domains) member 1
PLEKHD1; pleckstrin homology domain containing, family D (with coiled-coil domains) member 1; pleckstrin homology domain containing, family D (with M protein repeats) member 1; UPF0639 protein; UPF0639;
SH3PXD2A
SH3 and PX domains 2A
SH3PXD2A; SH3 and PX domains 2A; SH3 multiple domains 1 , SH3MD1; SH3 and PX domain-containing protein 2A; FISH; five SH3 domains; KIAA0418; adapter protein TKS5; adaptor protein TKS5; SH3 multiple domains 1; five SH3 domain-containing protein; tyrosine k;
RXFP2
relaxin/insulin-like family peptide receptor 2
RXFP2; relaxin/insulin-like family peptide receptor 2; leucine rich repeat containing G protein coupled receptor 8 , LGR8; relaxin receptor 2; GPR106; GREAT; INSL3R; RXFPR2; G protein coupled receptor 106; G protein coupled receptor affecting testicular descent; Leucine rich repeat containing G protein coupled receptor 8; LGR8; Relaxin family peptide receptor 2; RXFP 2; OTTHUMP00000018219; G-protein coupled receptor 106; G-protein coupled receptor affecting testicular descent; leucine-rich repeat-containing G protein-coupled receptor 8; leucine-rich repeat-containing G-protein coupled receptor 8; LGR8.1;
INSL5
insulin-like 5
INSL5; insulin-like 5; insulin-like peptide INSL5; insulin-like peptide 5; PRO182; UNQ156; MGC126695; MGC126697;
GAPVD1
GTPase activating protein and VPS9 domains 1
GAPVD1; GTPase activating protein and VPS9 domains 1; RAP6; GAPEX5; GAPex-5; GTPase-activating protein and VPS9 domain-containing protein 1; rab5-activating protein 6;
RXFP4
relaxin/insulin-like family peptide receptor 4
RXFP4; relaxin/insulin-like family peptide receptor 4; G protein coupled receptor 100 , GPR100, relaxin 3 receptor 2 , relaxin family peptide receptor 4 , RLN3R2; relaxin-3 receptor 2; GPCR142; RXFPR4; G protein coupled receptor 100; Relaxin 3 receptor 2; Relaxin family peptide receptor 4; RLN3R2; RLN3 receptor 2; G protein-coupled receptor 100; G-protein coupled receptor 100; G-protein coupled receptor GPCR142; insulin-like peptide INSL5 receptor; GPR100;
INSM1
insulinoma-associated 1
INSM1; insulinoma-associated 1; insulinoma-associated protein 1; IA1; Insulinoma associated protein 1; Zinc finger protein IA1; zinc finger protein IA-1; insulinoma-associated protein (IA-1); IA-1;
KIR2DS1
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1
KIR2DS1; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1; killer cell immunoglobulin-like receptor 2DS1; CD158H; EB6ActI; EB6ActII; p50.1; CD158 antigen-like family member H; CD158a; KI2S1_HUMAN; MHC class I NK cell receptor Eb6 ActI; XXbac-BCX195L8.7; KIR2DL1-KIR2DS1; killer-cell immunoglobulin-like receptor; killer cell immunoglobulin-like receptor KIRDS1;
INSIG1
insulin induced gene 1
INSIG1; insulin induced gene 1; insulin-induced gene 1 protein; CL 6; INSIG 1 membrane protein; MGC1405; CL6; INSI1_HUMAN; INSIG 1; INSIG-1; INSIG1 membrane protein; Insulin induced gene 1 protein; INSIG-1 membrane protein; CL-6;
INSL3
insulin-like 3 (Leydig cell)
INSL3; insulin-like 3 (Leydig cell); relaxin like factor , RLNL; insulin-like 3; MGC119818; MGC119819; RLF; ley-I-L; relaxin-like factor b; leydig insulin-like peptide; leydig insulin -like hormone; leydig insulin -like peptide; RLNL;
INSL4
insulin-like 4 (placenta)
INSL4; insulin-like 4 (placenta); early placenta insulin-like peptide; EPIL; early placenta insulin like peptide (EPIL); Early placenta insulin like peptide A chain; Early placenta insulin like peptide; Early placenta insulin like peptide B chain; Early placenta insulin-like peptide A chain; INSL4_HUMAN; insulin like 4; insulin like 4 (placenta); Insulin like peptide 4; Insulin-like peptide 4; OTTHUMP00000021025; Placentin; early placenta insulin-like peptide (EPIL);
INSM2
insulinoma-associated 2
INSM2; insulinoma-associated 2; insulinoma-associated protein 2; IA 6; mlt 1; zinc finger protein IA-6; insulinoma-associated protein IA-6; IA6; IA-6; mlt1;
IPPK
inositol 1,3,4,5,6-pentakisphosphate 2-kinase
IPPK; inositol 1,3,4,5,6-pentakisphosphate 2-kinase; C9orf12, chromosome 9 open reading frame 12; inositol-pentakisphosphate 2-kinase; FLJ13163; INSP5K2; IP5K; IPK1; 3; 4; 5; 6)P5 2-kinase; 6-pentakisphosphate 2-kinase; bA476B13.1 (novel protein); C9orf12; inositol 1,3,4,5,6 pentakisphosphate 2 kinase; Inositol pentakisphosphate 2 kinase; Inositol-1; Ins; Ins(1; InsP5 2 kinase; InsP5 2-kinase; IPK1 homolog; IPPK_HUMAN; ins(1,3,4,5,6)P5 2-kinase; bA476B13.1;
IGF2BP1
insulin-like growth factor 2 mRNA binding protein 1
IGF2BP1; insulin-like growth factor 2 mRNA binding protein 1; insulin-like growth factor 2 mRNA-binding protein 1; IGF II mRNA binding protein 1; IMP 1; ZBP-1; VICKZ family member 1; zipcode-binding protein 1; IGF2 mRNA-binding protein 1; IGF-II mRNA-bind;
LIM2
lens intrinsic membrane protein 2, 19kDa
LIM2; lens intrinsic membrane protein 2, 19kDa; lens intrinsic membrane protein 2 (19kD); lens fiber membrane intrinsic protein; MP17; MP19; Lens intrinsic membrane protein 2 19kDa; Lens intrinsic membrane protein 2; LIM 2; LMIP_HUMAN; MP18; MP20; To3;
LIMS2
LIM and senescent cell antigen-like domains 2
LIMS2; LIM and senescent cell antigen-like domains 2; LIM and senescent cell antigen-like-containing domain protein 2; FLJ10044; LIM-like protein 2; LIMS2_HUMAN; Particularly interesting new Cys-His protein 2; PINCH-2; ILK-binding protein; PINCH2;
SPECC1
sperm antigen with calponin homology and coiled-coil domains 1
SPECC1; sperm antigen with calponin homology and coiled-coil domains 1; cytospin-B; cytokinesis and spindle organization B; cytospin B; CYTSB; FLJ36955; HCMOGT 1; NSP; sperm antigen HCMOGT 1; NSP5; sperm antigen HCMOGT-1; structure protein NSP5a3a; struct;
MCTP1
multiple C2 domains, transmembrane 1
MCTP1; multiple C2 domains, transmembrane 1; multiple C2 and transmembrane domain-containing protein 1; FLJ22344; 2810465F10Rik; MCTP 1; Multiple C2 and transmembrane domain containing protein 1; Multiple C2 domains transmembrane 1; Multiple C2 domains with two transmembrane regions 1; OTTMUSP00000031345; RGD1305199; multiple C2-domains with two transmembrane regions 1;
MCTP2
multiple C2 domains, transmembrane 2
MCTP2; multiple C2 domains, transmembrane 2; multiple C2 and transmembrane domain-containing protein 2; FLJ11175; FLJ33303; MGC111402; Multiple C2 and transmembrane domain containing protein 2; Multiple C2-domains with two transmembrane regions 2; multiple C2-domains with two transmembrane regions 2 1;
KIR2DS2
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2
KIR2DL+KIR2DS1+KIR2DS2; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2; KIR2DS2; killer cell immunoglobulin-like receptor 2DS2; 183ActI; CD158J; cl 49; nkat5; NKAT-5; p58 KIR; 1060P11.9.2; NK receptor 183 ActI; p58 NK receptor CL-49; MHC class I;
KIR2DS5
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5
KIR2DS5; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5; killer cell immunoglobulin-like receptor 2DS5; CD158G; nkat9; CD158 antigen like family member G; Flags: Precursor; Killer cell immunoglobulin like receptor 2DS5; Killer cell immunoglobulin like receptor two domains short cytoplasmic tail 5; MHC class I NK cell receptor; Natural killer associated transcript 9; Natural killer cell inhibitory receptor; NKAT 9; NKAT-9; CD158 antigen-like family member G; natural killer-associated transcript 9;
KIR3DL2
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2
KIR3DL2; killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2; killer cell immunoglobulin-like receptor 3DL2; CD158K; cl 5; nkat4; nkat4a; nkat4b; CD158 antigen like family member K; CD158 antigen-like family member K; KI3L2_HUMAN; Killer cell immunoglobulin like receptor 3DL2; killer cell immunoglobulin like receptor KIR3DL2; Killer cell immunoglobulin like receptor, three domains, long cytoplasmic tail, 2; KIR antigen 3DL2; Kirl2; MHC class I NK cell receptor; Natural killer associated transcript 4; natural killer cell inhibitory receptor; Natural killer-associated transcript 4; NK associated transcript 4; NK associated transcript 4A, included; NK associated transcript 4B, included; NKAT-4; p140; p70 natural killer cell receptor clone CL 5; p70 natural killer cell receptor clone CL-5; p70 NK receptor CL 5; p70 NK receptor CL-5; killer Ig receptor; p70 killer cell inhibitory receptor; killer cell immunoglobulin-like receptor KIR3DL2;
LOC727787
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like
LOC727787; killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2-like; Killer cell immunoglobulin like receptor three domains long cytoplasmic tail 2 like; LOC727787|-|-;
LIMCH1
LIM and calponin homology domains 1
LIMCH1; LIM and calponin homology domains 1; LIM and calponin homology domains-containing protein 1; DKFZP686A01247; LIMCH1A; LMO7B; DKFZp434I0312; DKFZp686B2470; DKFZp686G18243; DKFZp686G2094; DKFZp781C1754; DKFZp781I1455; KIAA1102; LIM and calponin homology domains containing protein 1; LIMCH 1; MGC72127; OTTHUMP00000218619;
LRIG1
leucine-rich repeats and immunoglobulin-like domains 1
LRIG1; leucine-rich repeats and immunoglobulin-like domains 1; leucine-rich repeats and immunoglobulin-like domains protein 1; DKFZP586O1624; leucine rich repeat protein LRIG1; LIG 1; LIG1; ortholog of mouse integral membrane glycoprotein LIG 1; Leucine rich repeat protein; leucine rich repeats and immunoglobulin like domains 1; LIG-1; LRIG1_HUMAN; OTTHUMP00000213345; OTTHUMP00000213346; leucine-rich repeat protein LRIG1; ortholog of mouse integral membrane glycoprotein LIG-1;
MEGF11
multiple EGF-like-domains 11
MEGF11; multiple EGF-like-domains 11; multiple epidermal growth factor-like domains protein 11; DKFZp434L121; KIAA1781; MEG11_HUMAN; Multiple EGF-like domains protein 11;
MEGF9
multiple EGF-like-domains 9
MEGF9; multiple EGF-like-domains 9; EGF like domain, multiple 5 , EGFL5; multiple epidermal growth factor-like domains protein 9; EGF-like-domain, multiple 5; epidermal growth factor-like protein 5; EGFL5;
MS4A14
membrane-spanning 4-domains, subfamily A, member 14
MS4A14; membrane-spanning 4-domains, subfamily A, member 14; membrane spanning 4 domains, subfamily A, member 16 , MS4A16; membrane-spanning 4-domains subfamily A member 14; DKFZp434H092; FLJ32856; NYD SP21; MS4A13; Testis development protein NYD SP21; Testis development protein NYDSP21; Membrane spanning 4 domains subfamily A member 14; Membrane spanning 4 domains subfamily A member 16; MGC104289; MGC49828; MS4A13 protein; MS4A16; NYDSP21; Testis development related NYD SP21; Testis development related NYDSP21; testes development-related NYD-SP21; testis development protein NYD-SP21; membrane-spanning 4-domains, subfamily A, member 16; NYD-SP21;
MS4A3
membrane-spanning 4-domains, subfamily A, member 3 (hematopoietic cell-specific)
MS4A3; membrane-spanning 4-domains, subfamily A, member 3 (hematopoietic cell-specific); CD20L; membrane-spanning 4-domains subfamily A member 3; HTM4; CD20 antigen homolog; CD20 antigen like; CD20 antigen like protein; hematopoietic cell 4 transmembrane protein; Hematopoietic-specific transmembrane protein 4; IgE receptor beta subunit; OTTHUMP00000235850; OTTHUMP00000235851; OTTHUMP00000235853; IgE receptor beta chain; CD20 antigen-like protein;
MS4A4A
membrane-spanning 4-domains, subfamily A, member 4
MS4A4A; membrane-spanning 4-domains, subfamily A, member 4; MS4A4; membrane-spanning 4-domains subfamily A member 4A; CD20L1; MS4A7; 4SPAN1; CD20 antigen like 1; CD20 antigen-like 1; four-span transmembrane protein 1; Fc epsilon receptor beta subunit homolog; membrane-spanning 4-domains, subfamily A, member 4A; CD20-L1; HDCME31P;
MS4A5
membrane-spanning 4-domains, subfamily A, member 5
MS4A5; membrane-spanning 4-domains, subfamily A, member 5; membrane-spanning 4-domains subfamily A member 5; CD20L2; Testis expressed transmembrane 4 protein; CD20 antigen like 2; Membrane spanning 4 domains subfamily A member 5; TETM4; CD20 antigen-like 2; testis-expressed transmembrane protein 4; testis-expressed transmembrane-4 protein; CD20-L2;
MYSM1
Myb-like, SWIRM and MPN domains 1
MYSM1; Myb-like, SWIRM and MPN domains 1; histone H2A deubiquitinase MYSM1; KIAA1915; 2A-DUB; 2ADUB; Histone H2A deubiquitinase; Myb like SWIRM and MPN domains 1; Myb-like; MYSM 1; MYSM1 Myb-like, SWIRM and MPN domains 1; MYSM1_HUMAN; SWIRM and MPN domain-containing protein 1; myb-like, SWIRM and MPN domain-containing protein 1; RP4-592A1.1;
NUB1
negative regulator of ubiquitin-like proteins 1
NUB1; negative regulator of ubiquitin-like proteins 1; NEDD8 ultimate buster 1; BS4; NYREN18; NEDD8 ultimate buster-1; renal carcinoma antigen NY-REN-18; NUB1L;
ITGBL1
integrin, beta-like 1 (with EGF-like repeat domains)
ITGBL1; integrin, beta-like 1 (with EGF-like repeat domains); integrin beta-like protein 1; integrin beta like 1; OSCP; ten integrin EGF like repeat domains protein; TIED; osteoblast-specific cysteine-rich protein; ten integrin EGF-like repeat domains pro;
PGAP3
post-GPI attachment to proteins 3
PGAP3; post-GPI attachment to proteins 3; per1 like domain containing 1 , PERLD1; post-GPI attachment to proteins factor 3; CAB2; MGC9753; PER1; post GPI attachment to proteins 3; PP1498; hCOS16; COS16 homolog; per1-like domain containing 1; gene coamplif;
TKV
thickveins
TKV; thickveins; CG14026 gene product from transcript CG14026-RA; Thick veins protein; thickveins, isoform A; CG14026-PA; tkv-PA; Thick-vein; Activin-A-receptor-25D; DPP receptor; BMP receptor kinase 25D; thickvein; thick veins; slater; thickveins, isoform C; CG14026-PC; tkv-PC; thickveins, isoform B; CG14026-PB; tkv-PB; thickveins, isoform D; CG14026-PD; tkv-PD; Atkv; Atr25D; Brk25D; Brk25D1; Brk25D2; CG14026; Dmel\CG14026; dtfr; kv; l(2)04415; l(2)25Da; STK-A; str; tkv1;
PLEKHB2
pleckstrin homology domain containing, family B (evectins) member 2
PLEKHB2; pleckstrin homology domain containing, family B (evectins) member 2; pleckstrin homology domain-containing family B member 2; EVT2; FLJ20783; Evectin 2; Evectin2; FLJ23679; FLJ30436; Pleckstrin homology domain containing family B member 2; evectin-2; OTTHUMP00000162428; OTTHUMP00000197850; OTTHUMP00000203955; OTTHUMP00000203956; OTTHUMP00000205940; PH domain-containing family B member 2;
RC3H1
ring finger and CCCH-type domains 1
RC3H1; ring finger and CCCH-type domains 1; ring finger and CCCH type zinc finger domains 1; roquin; KIAA2025; KIAA2025 protein; RNF198; RP5 1198E17.5; RING finger protein 198; RING finger and C3H zinc finger protein 1; ring finger and CCCH-type zinc fing;
RC3H2
ring finger and CCCH-type domains 2
RC3H2; ring finger and CCCH-type domains 2; membrane associated DNA binding protein , MNAB, ring finger and CCCH type zinc finger domains 2; RING finger and CCCH-type zinc finger domain-containing protein 2; FLJ20301; FLJ20713; RNF164; 2900024N03Rik; 9430019J22Rik; D930043C02Rik; MGC52176; OTTMUSP00000013546; RING finger and CCCH type zinc finger domain containing protein 2; Membrane associated DNA binding protein; Membrane associated nucleic acid binding protein; Membrane-associated nucleic acid-binding protein; MNAB; OTTHUMP00000022076; OTTHUMP00000022077; OTTMUSP00000013545; RC3H2_HUMAN; Ring finger and CCCH type domains 2; RING finger protein 164; RP23-321B3.1; ring finger and CCCH-type zinc finger domains 2; membrane-associated nucleic acid binding protein;
GINS1
GINS complex subunit 1 (Psf1 homolog)
GINS1; GINS complex subunit 1 (Psf1 homolog); DNA replication complex GINS protein PSF1; KIAA0186; PSF1; GINS complex subunit 1; partner of sld five-1; partner of sld5; PSF1 homolog; RP4-691N24.2;
GINS3
GINS complex subunit 3 (Psf3 homolog)
GINS3; GINS complex subunit 3 (Psf3 homolog); DNA replication complex GINS protein PSF3; FLJ13912; PSF3; GINS complex subunit 3; PSF3 homolog;
PTPLA
protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A
PTPLA; protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A; protein tyrosine phosphatase like (proline instead of catalytic arginine), member a; 3-hydroxyacyl-CoA dehydratase 1; CAP; cementum attachment protein; HACD1; HACD1_HUMAN; Protein-tyrosine phosphatase-like member A; RP23-334M9.1;
PTPLB
protein tyrosine phosphatase-like (proline instead of catalytic arginine), member b
PTPLB; protein tyrosine phosphatase-like (proline instead of catalytic arginine), member b; 3-hydroxyacyl-CoA dehydratase 2; 3 hydroxyacyl CoA dehydratase 2; HACD2; Protein tyrosine phosphatase like (proline instead of catalytic arginine) member b; Protein tyrosine phosphatase like member B; protein-tyrosine phosphatase-like member B;
RADIL
Ras association and DIL domains
RADIL; Ras association and DIL domains; ras-associating and dilute domain-containing protein; FLJ10324; KIAA1849; RASIP2; FLJ60975; MGC161589; RADIL_HUMAN; Rap GTPase interactor; OTTHUMP00000200468;
RPH3AL
rabphilin 3A-like (without C2 domains)
RPH3AL; rabphilin 3A-like (without C2 domains); rab effector Noc2; Noc2; no C2 domains protein;
SESTD1
SEC14 and spectrin domains 1
SESTD1; SEC14 and spectrin domains 1; SEC14 domain and spectrin repeat-containing protein 1; DKFZp434O0515; Solo; huntingtin interacting protein like protein; Huntingtin-interacting protein-like protein; Protein Solo; SESD1_HUMAN;
SPECC1L
sperm antigen with calponin homology and coiled-coil domains 1-like
SPECC1L; sperm antigen with calponin homology and coiled-coil domains 1-like; SPECC1 like; cytospin-A; cytokinesis and spindle organization A; cytospin A; CYTSA; KIAA0376; CYTSA_HUMAN; Renal carcinoma antigen NY-REN-22; SPECC1-like protein; OBLFC1;
SNED1
sushi, nidogen and EGF-like domains 1
SNED1; sushi, nidogen and EGF-like domains 1; sushi, nidogen and EGF-like domain-containing protein 1; FLJ00133; Snep; SST3; DKFZp586B2420; Insulin responsive sequence DNA binding protein 1; IRE BP1; Sushi, nidogen and EGF like domain containing protein 1; sushi, nidogen and EGF like domains 1; IRE-BP1; 6720455I24Rik homolog; insulin responsive sequence DNA binding protein-1; insulin-responsive sequence DNA-binding protein 1;
SPNS2
spinster homolog 2 (Drosophila)
SPNS2; spinster homolog 2 (Drosophila); protein spinster homolog 2; spinster homolog 2; SPNS 2; SPNS2 protein;
SPNS3
spinster homolog 3
SPNS3; spinster homolog 3 (Drosophila); protein spinster homolog 3; MGC29671;
SPOCK1
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1
SPOCK1; sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1; sparc/osteonectin, cwcv and kazal like domains proteoglycan (testican) , SPOCK, TIC1; testican-1; testican 1; Sparc/osteonectin, cwcv and kazal like domains proteoglycan 1; SPOCK; TIC1; TICN1; TESTICAN;
SPOCK2
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2
SPOCK2; sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2; testican-2; KIAA0275; testican 2; and Kazal-like domains proteoglycan 2; CWCV; FLJ97039; SPARC/osteonectin; Sparc/osteonectin cwcv and kazal like domains proteoglycan (testican) 2; Sparc/osteonectin cwcv and kazal like domains proteoglycan 2; SPOCK 2; Testican2; TICN 2; TICN2; TICN2_HUMAN; SPARC/osteonectin, CWCV, and Kazal-like domains proteoglycan 2;
TC2N
tandem C2 domains, nuclear
TC2N; tandem C2 domains, nuclear; C14orf47, chromosome 14 open reading frame 47 , membrane targeting (tandem) C2 domain containing 1 , MTAC2D1; tandem C2 domains nuclear protein; C2 calcium dependent domain containing 1; C2CD1; FLJ36557; Tac2 N; tandem;
TMCO3
transmembrane and coiled-coil domains 3
TMCO3; transmembrane and coiled-coil domains 3; C13orf11, chromosome 13 open reading frame 11; transmembrane and coiled-coil domain-containing protein 3; FLJ20623; C13orf11; Chromosome 13 open reading frame 11; Putative LAG1 interacting protein; Putative LAG1-interacting protein; TMCO3_HUMAN; Transmembrane and coiled coil domains 3; B230339H12Rik; OTTHUMP00000018770;
TMCO4
transmembrane and coiled-coil domains 4
TMCO4; transmembrane and coiled-coil domains 4; transmembrane and coiled-coil domain-containing protein 4; DKFZp686C23231; RP5-1056L3.6;
TMCO6
transmembrane and coiled-coil domains 6
TMCO6; transmembrane and coiled-coil domains 6; transmembrane and coiled-coil domain-containing protein 6; FLJ39769; PRO1580;
TMCO7
transmembrane and coiled-coil domains 7
TMCO7; transmembrane and coiled-coil domains 7; transmembrane and coiled-coil domain-containing protein 7; FLJ12688; KIAA1746;
UACA
uveal autoantigen with coiled-coil domains and ankyrin repeats
UACA; uveal autoantigen with coiled-coil domains and ankyrin repeats; FLJ10128; KIAA1561; MGC141967; MGC141969; NUCLING; Uveal autoantigen with coiled coil domains and ankyrin repeats; nuclear membrane binding protein;
AGGF1
angiogenic factor with G patch and FHA domains 1
AGGF1; angiogenic factor with G patch and FHA domains 1; FLJ10283; GPATC7; GPATCH7; HSU84971; VG5Q; angiogenic factor VG5Q; vasculogenesis gene on 5q protein; G patch domain-containing protein 7; HUS84971;
UEVLD
UEV and lactate/malate dehyrogenase domains
UEVLD; UEV and lactate/malate dehyrogenase domains; ubiquitin-conjugating enzyme E2 variant 3; Attp; UEV3; 8430408E05Rik; EV and lactate malate dehydrogenase domain containing protein; EV and lactate/malate dehydrogenase domain-containing protein; FLJ11068; signaling molecule ATTP; ubiquitin conjugating enzyme E2 like; Ubiquitin conjugating enzyme E2 variant 3; Ubiquitin E2 variant and lactate/malate dehydrogenase domain containing protein; UEV 3; UEV and lactate malate dehyrogenase domains; UEV-3; UEV2 and LDH domains containing protein; UEVLD_HUMAN;
ZKSCAN2
zinc finger with KRAB and SCAN domains 2
ZKSCAN2; zinc finger with KRAB and SCAN domains 2; zinc finger protein 694 , ZNF694; zinc finger protein with KRAB and SCAN domains 2; FLJ23199; Zinc finger protein 694; ZKSC2_HUMAN; zinc finger and SCAN domain containing 31; ZNF694; ZSCAN31;
ZKSCAN14
zinc finger with KRAB and SCAN domains 14
ZKSCAN14; zinc finger with KRAB and SCAN domains 14; zinc finger protein 394; Zinc finger protein with KRAB and SCAN domains 14; ZN394_HUMAN; Znf394; zfp-94; zinc finger protein 94; zinc finger protein 99; Zfp99; 2310046C23Rik; 2810437E14Rik;
KANK3
KN motif and ankyrin repeat domains 3
KANK3; KN motif and ankyrin repeat domains 3; ANKRD47, ankyrin repeat domain 47; KN motif and ankyrin repeat domain-containing protein 3; FLJ46061; Ankyrin repeat domain containing protein 47; ANKRD47; Ankyrin repeat domain 47; Kidney ankyrin repeat containing protein 3; KN motif and ankyrin repeat domain containing protein 3; Ng28; kidney ankyrin repeat-containing protein 3; ankyrin repeat domain-containing protein 47;
Insulin Aspart
Insulin Aspart
Aspart; Aspart Insulin; B28-Aspart-Insulin; INA-X14; Insulin X14; Insulin, Asp(B28); Insulin Aspart;
CK
Cytokinins
CK; Cytokinins; Isopentenyladenosine, isopentenyladenine and benzyladenine riboside; Isopentenyladenosine; isopentenyladenine; benzyladenine riboside;
KIR2DL5A
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5A
KIR2DL5A; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5A; CD158F; KIR2DL5; KIR2DL5.1;
KIR3DS1
killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1
KIR3DS1;killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1;killer cell immunoglobulin-like receptor 3DS1;nkat10;NKAT-10;killer Ig receptor;MHC class I NK cell receptor;natural killer-associated transcript 10;killer cell immunoglobulin-like receptor KIR3DS1;KIR-G1;NKAT10;CD158E2;KIR-123FM;MGC119726;MGC119728;MGC125316;
Shank2
SH3 and multiple ankyrin repeat domains 2
SHANK2;SH3 and multiple ankyrin repeat domains 2;ENSRNOG00000029931;CortBP1;ProSAP1;Spank-3;1q41;SH3 and multiple ankyrin repeat domains protein 2;SH3 and multiple ankyrin repeat domains protein 2;SH3/ankyrin domain gene 2;cortactin-binding protein 1;GKAP/SAPAP-interacting protein;proline rich synapse associated protein 1;proline-rich synapse-associated protein 1;
CRELD1
cysteine-rich with EGF-like domains 1
Creld1; AI843811; cysteine-rich with EGF-like domains 1; cysteine-rich with EGF-like domain protein 1; i11E7 protein;
LILRB4
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4
LILRB4;leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4;6608;ENSG00000186818;HM18;ILT3;LIR5;CD85K;LIR-5;LILRB5;19q13.4;leukocyte immunoglobulin-like receptor subfamily B member 4;leukocyte immunoglobulin-like receptor subfamily B member 4;ILT-3;immunoglobulin-like transcript 3;CD85 antigen-like family member K;monocyte inhibitory receptor HM18;leukocyte immunoglobulin-like receptor 5;leukocyte immunoglobulin-like receptor, subfamily B, member 4;leukocyte immunoglobulin-like receptor subfamily B member 4 soluble isoform;
FCHSD2
FCH and double SH3 domains 2
FCHSD2;FCH and double SH3 domains 2;29114;ENSG00000137478;NWK;SH3MD3;11q13.4;KIAA0769;FCH and double SH3 domains protein 2;FCH and double SH3 domains protein 2;carom;nervous wreck homolog;SH3 multiple domains 3;SH3 multiple domains protein 3;
GINS4
GINS complex subunit 4
GINS complex subunit 4; GINS4; SLD5 homolog; SLD5; MGC14799; GINS complex subunit 4 (Sld5 homolog); 2810037C03Rik; 4933405K01Rik; DNA replication complex GINS protein SLD5;
INSL6
insulin-like 6
INSL6;insulin-like 6;6089;ENSG00000120210;RIF1;9p24;insulin-like peptide INSL6;insulin-like peptide INSL6;insulin-like peptide 5;insulin-like peptide 6;relaxin/insulin-like factor 1;
KANK4
KN motif and ankyrin repeat domains 4
KANK4;KN motif and ankyrin repeat domains 4;27263;ENSG00000132854;ANKRD38;dJ1078M7.1;RP5-1155K23.5;1p31.3;FLJ10884, KIAA0172;KN motif and ankyrin repeat domain-containing protein 4;KN motif and ankyrin repeat domain-containing protein 4;ankyrin repeat domain 38;kidney ankyrin repeat-containing protein 4;ankyrin repeat domain-containing protein 38;
LILRB5
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5 [ Homo sap
LILRB5;leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5;6609;ENSG00000105609;LIR8;CD85C;LIR-8;19q13.4;leukocyte immunoglobulin-like receptor subfamily B member 5;leukocyte immunoglobulin-like receptor subfamily B member 5;CD85 antigen-like family member C;leukocyte immunoglobulin-like receptor 8;
LRIT1
leucine-rich repeat, immunoglobulin-like and transmembrane domains 1
LRIT1;leucine-rich repeat, immunoglobulin-like and transmembrane domains 1;23404;ENSG00000148602;PAL;LRRC21;FIGLER9;10q23;DKFZp434K091;leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 1;leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 1;retina-specific protein PAL;leucine rich repeat containing 21;leucine-rich repeat-containing protein 21;photoreceptor-associated LRR superfamily protein;fibronectin type III, immunoglobulin and leucine rich repeat domains 9;
LRIG2
leucine-rich repeats and immunoglobulin-like domains 2
LRIG2;leucine-rich repeats and immunoglobulin-like domains 2;20889;ENSG00000198799;LIG2;LIG-2;1p13.1;KIAA0806, DKFZp451C181;leucine-rich repeats and immunoglobulin-like domains protein 2;leucine-rich repeats and immunoglobulin-like domains protein 2;
LRIT2
leucine-rich repeat, immunoglobulin-like and transmembrane domains 2
LRIT2;leucine-rich repeat, immunoglobulin-like and transmembrane domains 2;23443;ENSG00000204033;LRRC22;10q23.1;leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 2;leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 2;leucine rich repeat containing 22;leucine-rich repeat-containing protein 22;
LRTM1
leucine-rich repeats and transmembrane domains 1
LRTM1;leucine-rich repeats and transmembrane domains 1;25023;ENSG00000144771;HT017;3p14.3;leucine-rich repeat and transmembrane domain-containing protein 1;leucine-rich repeat and transmembrane domain-containing protein 1;
MS4A13
membrane-spanning 4-domains, subfamily A, member 13
MS4A13;membrane-spanning 4-domains, subfamily A, member 13;16674;ENSG00000204979;11q12.2;membrane-spanning 4-domains subfamily A member 13;membrane-spanning 4-domains subfamily A member 13;testis-expressed transmembrane protein 4;testis-expressed transmembrane-4 protein;
PDDC1
Parkinson disease 7 domain containing 1
PDDC1;Parkinson disease 7 domain containing 1;26616;ENSG00000177225;11p15.5;FLJ34283, FLJ35497, MGC131881, MGC138350;Parkinson disease 7 domain-containing protein 1;Parkinson disease 7 domain-containing protein 1;
RAPH1
Ras association (RalGDS/AF-6) and pleckstrin homology domains 1
RAPH1;Ras association (RalGDS/AF-6) and pleckstrin homology domains 1;14436;ENSG00000173166;LPD;RMO1;PREL2;PREL-2;ALS2CR9;ALS2CR18;RalGDS/AF-6;2q33;KIAA1681;ras-associated and pleckstrin homology domains-containing protein 1;ras-associated and pleckstrin homology domains-containing protein 1;lamellipodin;proline-rich EVH1 ligand 2;amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 9;amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 18;amyotrophic lateral sclerosis 2 chromosomal region candidate gene 9 protein;amyotrophic lateral sclerosis 2 chromosomal region candidate gene 18 protein;
SFMBT2
Scm-like with four mbt domains 2
SFMBT2;Scm-like with four mbt domains 2;20256;ENSG00000198879;10p14;scm-like with four MBT domains protein 2;scm-like with four MBT domains protein 2;Scm-related gene containing four mbt domains 2;
SPNS1
spinster homolog 1 (Drosophila)
SPNS1;spinster homolog 1 (Drosophila);30621;ENSG00000169682;LAT;nrs;SPIN1;SPINL;HSpin1;PP2030;16p11.2;FLJ38358;protein spinster homolog 1;protein spinster homolog 1;spinster-like protein 1;
CSMD3
CUB and Sushi multiple domains 3
CSMD3;CUB and Sushi multiple domains 3;19291;ENSG00000164796;8q23.3;KIAA1894;CUB and sushi domain-containing protein 3;CUB and sushi domain-containing protein 3;CUB and sushi multiple domains protein 3;
CUZD1
CUB and zona pellucida-like domains 1
CUZD1;CUB and zona pellucida-like domains 1;17937;ENSG00000138161;ERG-1;UO-44;10q26.13;CUB and zona pellucida-like domain-containing protein 1;CUB and zona pellucida-like domain-containing protein 1;estrogen regulated gene 1;transmembrane protein UO-44;CUB and ZP domain-containing protein 1;
RMI2
RMI2, RecQ mediated genome instability 2, homolog (S. cerevisiae)
RMI2;RMI2, RecQ mediated genome instability 2, homolog (S. cerevisiae);28349;ENSG00000175643;BLAP18;C16orf75;16p13.13;MGC24665;recQ-mediated genome instability protein 2;recQ-mediated genome instability protein 2;hRMI2;BLM-associated protein of 18 kDa;RecQ-mediated genome instability 2, S. cerevisiae, homolog of;
CSMD2
CUB and Sushi multiple domains 2
CSMD2;CUB and Sushi multiple domains 2;19290;ENSG00000121904;dJ947L8.1;dJ1007G16.1;dJ1007G16.2;1p34.3;KIAA1884;CUB and sushi domain-containing protein 2;CUB and sushi domain-containing protein 2;CUB and Sushi (SCR repeat) domain;CUB and sushi multiple domains protein 2;
Megf10
multiple EGF-like-domains 10
MEGF10;multiple EGF-like-domains 10;ENSMUSG00000024593;Gm331;3000002B06Rik;18 D3;18;multiple epidermal growth factor-like domains protein 10;multiple epidermal growth factor-like domains protein 10;multiple EGF-like domains protein 10;
DZANK1
double zinc ribbon and ankyrin repeat domains 1
ANKRD64; C20orf12; C20orf84; dJ568F9.2; bA189K21.1; bA189K21.8;
KIR3DL3
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3
KIR44; KIRC1; CD158Z; KIR3DL7;
Lilrb3l
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3-like
Pirb; Lilrb3; Pir-A1; Pir-A2;
PLEKHB1
pleckstrin homology domain containing, family B (evectins) member 1
PLEKHB1; pleckstrin homology domain containing, family B (evectins) member 1; KPL1; PHR1; PHRET1;
A630055G03Rik
RMI2, RecQ mediated genome instability 2, homolog (S. cerevisiae)
Gm537; Gm929; A630055G03Rik;
RGD1309228
similar to putative protein, with at least 9 transmembrane domains, of eukaryotic origin (43.9 kD) (2G415)
TMCO1
transmembrane and coiled-coil domains 1
ESTM39; AA109065; AU022572; 1190006A08Rik; 4930403O06Rik;
Cbp
Calcium-binding proteins
CBP Epitope Tag; Calmodulin Binding Protein Epitope Tag; CBP; Calcium-binding proteins;
Pgap2
PGAP2 post-GPI attachment to proteins 2 [ Homo sapiens ]
post-GPI attachment to proteins 2; 17893; Ensembl:ENSG00000148985; MGC799, FLJ26520; post-GPI attachment to proteins factor 2; FGF receptor activating protein 1; FGF receptor-activating protein 1; cell wall biogenesis 43 N-terminal homolog; FRAG1; CWH43-N;
RGD1309594
similar to RIKEN cDNA 1810043G02; DNA segment, Chr 10, Johns Hopkins University 13, expressed
IGFII
insulin-like growth factor 2 (somatomedin A)
IGF-II; PP9974; C11orf43; IGF2; insulin-like growth factor 2 (somatomedin A); insulin-like growth factor II; somatomedin-A; insulin-like growth factor type 2; GF2; FLJ22066; FLJ44734;
Baculovirus-Insect Cell Expression
At Creative BioMart, our team of experts have developed baculovirus-insect cell expression platform for virus production and recombinant protein manufacture in various scales. The ability of Creative BioMart's baculovirus-insect cell system to express proteins with complex post-translational modific...
Renaturation of Recombinant Proteins from Inclusion Bodies
Recombinant proteins expressed in bacteria often form inclusion bodies, especially when they are expressed at high levels. Creative BioMart retrieves expressed GST fusion protein in soluble form after lysis and extraction procedures. Advantages: Specifically for solubilizing and renaturing GST in...
Human Synthetic Proteins Produced in Mammalian Cell Lines
Creative BioMart has developed a novel approach to both increase biological activities and reduce production costs of human synthetic proteins in mammalian cell lines. The stable transfection of particular cell lines with human sialyltransferases (a set of enzymes involves in protein glycosylation) ...
We offer labeled proteins using our catalogue products
Featured different labeling techniques types of label are available: Biotinylation Enzymatic labeling: HRP, AP, etc. Fluorescent labeling: R-PE, APC, FITC, RBITC, Cy3, Cy5, Cy5.5, Cy7, etc. Co-Au Labeling Chemicals Labeling Drug labeling Others Find biotinylated proteins of your interest at Biotin...
Magnetic Bead-Coupled Proteins and Nucleic Acids
Biocoupling is the process of covalent binding of two biomolecules. Standard biochemical couplings include amine coupling of amino acid residues of lysine, sulfhydryl coupling of cysteine residues, and often photochemically initiated free radical reactions. The product of a bio-coupling is a bioconj...
Membrane Proteins Expression and Purification
Membrane proteins play an essential role in many life activities of living organisms, such as cell proliferation and differentiation, energy conversion, signal transduction, and material transport. It is estimated that about 60% of drug targets are membrane proteins. Membrane proteins are important ...
Cell: Researchers Found a Novel Rule of Membrane Proteins
Like the teeth of a zipper, the charged amino acids (as the red and blue color show) form connections between protein segments and thus form pores in the cell membrane. Membrane proteins, attached to or associated with themembraneof acellor anorganelle, perform a variety of functions vita...
Researchers Developed a Model That Explains How Nucleosomes Recognize Protein
The pictures shows the model how proteins move along DNA Most of the DNA in evolved organisms is wrapped around proteins, forming the basic unit of DNA packaging, nucleosomes as the picture shows. But how exactly these nucleosomes are recognized and read by protein is unclear. In order to fin...
PNAS: Scientists Unveiled a Novel Feature of DEAD-box Proteins
As reported on the Early Edition of the Proceeding of the National Academy of Science on Apr. 29, 2013, scientists have uncovered how DEAD-box proteins and its cofactors can specifically work on other proteins with nonspecific biochemical activity. DEAD-box proteins are a large class of RNA-depen...
Scientists Found a New Method to Understand Ion Channel Proteins
Photograph of integrated amplifiers. The well supporting the membrane and channel is noted in the figure. Ion channel are key regulators of cellular function. They are a critical group of important membrane protein drug targets and account for the activity of 10% of the currently marketed drugs...
How Some Enzymes Involved in the Handling of Defective Proteins
The 2004 Nobel Prize in Chemistry went to scientists who found the protective program of ubiquitin-mediated protein degradation. Now a group of scientists found some enzymes that got involved in the degradation of defective proteins for the first time. It is well known that many cells are produce...
Scientists Revealed How Genes Translate into Proteins on Molecular Level
In the picture, the green presents the messenger RNA, the brown presents the elongation factor EF-G, and the four sequential positions of transfer RNA as it moves from right to left during translocation (dark blue, light blue, red, and gray). Have you ever wondered how ribosome translates gen...
Angewandte Chemie: The New Method to Make Therapeutic Proteins Last Longer
Nowadays therapeutic proteins are widely used to relieve sufferers from many conditions, such as cancers (Monoclonal antibodies, Interferons), heart disease and stroke (Enzymes, Blood factors), diabetes (Insulin), anaemia (Erythropoietin), haemophilia (Blood clotting factors) etc. and they show pr...
The Important Roles of MBNL Proteins in the Pluripotency of Stem Cells
Induced pluripotent stem cells are a vital research direction for the future academic and medical application. In past studies, scientists have paid much attention on the part of transcription, chromatin and non-coding RNA regulators of the pluripotency of embryonic stem (ES) cells. Alternative ...
Industry Analysis: The Application and Development Trend of Recombinant Proteins
Recombinant proteins are manufactured by genetic engineering, cell engineering or other technologies, derived from organisms. Recombinant proteins have become one of the most products for current biology industry. From a broad range, recombinant proteins include recombinant proteins of na...
A Reliable Recombinant Proteins Supplier
The application of recombinant proteins: To identify the polypeptide coded by a DNA-sequence To analyze the biological activity To study the structure-function relationships, interactions To study the 3D-structure To do protein engineering and design To raise specific antibodies To develop a ...
Virus-specific Antibody—New Clue to against Norovirus Infection
The picture shows its X-ray crystallographic structure It could be said that norovirus was identified in 1972 and got its current namenorovirus in 2002 approved by ICTV . ...
Nature: New Finding on Gene MX2 Brings Clue to Against HIV
Our knowledge about Gene MX2 is poorly understood. Now researchers found a new potential of anti-HIV. Magazine Nature published the latest new finding on anti-HIV. This is the first time that researchers identified the impact of gene MX2 on H...
Biomolecular Finding: New Toxic-antitoxic System May Help to Inspire New Antibiotics
The picture shows DnaN in complex with a peptide from DNA polymerase III. The toxin SocB likely disrupts this complex to arrest DNA replication by binding a region of DnaN near the residue marked in green. One of the reasons leading to trick...
Learn More about Protein Structure Evolution with “Ancient” Proteins
Several months ago, researchers found something that will enlighten peoples understanding on the course of protein structure evolution and give new ideas on the novel protein design in protein engineering and biotechnology. Under the existing conditions, researchers usuall...
Diagnose Parkinson's disease in Two Minutes
Every year in the United States, there are 50,000 newly diagnosed Parkinson's disease. It is a neurological disorder. When nerve cells in brain stop generating dopamine, the Parkinson's disease will occur as the dopamine helps control muscle movement. Without dopamine, the nerve cells cannot properl...
Two proteins, ATG12 and ATG5 Might Help People Developing Innovative Cancer Therapies
Scientists at The Scripps Research Institute (TSRI) have found two key subunits within a cell that helps maintaining cell health. They identified how the two proteins help create organelles. Their discoveries make people think about interfering with the formation of these organelles and lead to new ...
Blueprinting Proteins, Once Difficult Now Easier
Recently, a new study has brought hope to the blueprinting of a certain proteins, which is a big step forward in the field of drug discovery and development. Named in meso in situ serial crystallography (IMISX), this new method makes the job of blueprinting certain proteins relatively faster, cheape...
pSivida's Fluocinolone Insert Iluvien Get Negative Response in U.K. and U.S.
Iluvien, a fluocinolone insert for the treatment of vision loss in diabetes, developed using pSivida's Durasert technology and later its licensee was gained by Alimera Sciences, is an injectable microinsert which delivers the drug into the back of the eye for up to three years to treat chronic diabe...
Creative BioMart Launches Promotion Activity for Featured Recombinant Proteins This August
On July 28, 2014, Creative BioMart announced that it has launched the promotion of its featured recombinant proteins, which would be lasted from 1st, August to 31st, August. This promotion is for featured recombinant proteins, and any pur...
Creative BioMart Launches Promotions for Proteins, Enzymes and Custom Services this New Year
On December 22, 2014, just a few days before Christmas, Creative BioMart announced that it has launched the promotion of its featured Products. This special offer will expire on 1/31/2015. This promotion is for featured proteins, enzymes and custom services. Customers can save 10% for purchase of a...
Statistics: Research Focus Is Put on Recombinant Proteins
According to the results of one of our online surveys, most listed companies have placed their emphasis on the development of recombinant proteins. Meanwhile according to the statistics of financial weekly newspaper, nine pharmaceutical...
Featured Recombinant Proteins on Sale for August
Featured Recombinant Proteins On Sale For August: Buy Any Two Featured Recombinant Proteins, Save 20% Off, The Third 30% Off. These recombinant proteins have highly aggressive quality standards for specificity, sensitivity, and reproducibility. Limited time offer available until Aug 31,201...
Tell Us Your Story about You and Your Proteins
Who: This is for all scientists/students or anyone whose work is related to protein! Why: We would like to know the experience when you work with your proteins (recombinant protein, native protein, lysate etc.), no matter it is success or failure. Did you get on well with the protein or sti...
Proteins – Two for One Price
In 2022, extreme events, i.e., the epidemic, sustained heat, drought, and inflation, have surrounded our daily lives. We're glad that your continuous effort for biological research remained. To welcome the arrival of this new fall term, Creative BioMart has launched the BUY ONE GET ONE FREE promotio...
Guide of Analysis of Differentially Expressed Proteins by Two-dimensional Electrophoresis
Two-dimensional electrophoresis refers to isoelectric focusing electrophoresis in the first direction and SDS-PAGE in the second direction. After the charge and relative molecular weight of the sample are separated twice, the isoelectric point and relative molecular weight of the molecule can be obt...
Protocol of Affinity Enrichment of Phosphorylated Proteins
The important role of phosphorylated protein in cell life activities has made it a hotspot in proteomics research. However, the content of phosphorylated proteins in organisms is very low, and only a few proteins phosphorylate under specific stimulation; Secondly, phosphorylation modification has va...
Refolding of Inclusion Body Proteins from <em>E. Coli</em>
Expression of proteins in E. coli often leads to the formation of dense insoluble particles, known as inclusion bodies (IBs), containing most of the recombinant proteins in incorrect steric structures without the desired biological activities. How to obtain their native activity and structure, it is...
Protein Purification Instruction
By analyzing pure protein, we can determine amino acid sequences and investigate a proteins biochemical function. Besides, crystallization of proteins need pure protein, and we can obtain x-ray data from the protein crystals with a picture of tertiary structure, which is the actual functional unit...
